Alison Boyce
Chief, Metabolic Bone Disorders Unit at The National Institutes of Health · Boston Childrens Hospital
Credentials: · ·
History
- Present
Metabolic Bone Disorders Unit at The National Institutes of Health Division · Boston Childrens Hospital
- 2008–2011
Pediatrics
- 2004–2008
Doctor of Medicine
Research
Review · Orphanet Journal of Rare Diseases · 2019 · 228 citations
Denosumab treatment for fibrous dysplasia
Case report · Journal of Bone and Mineral Research · 2012 · First of 14 authors · 191 citations
Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation
Review · Endocrine Reviews · 2020 · First of 2 authors · 144 citations
Michael Collins
70 papers
- KP
18 papers · 12 as a resident
- RG
16 papers
- VS
10 papers · 6 as a fellow
- AB
7 papers
- EF
6 papers
6 papers · 6 as a resident
5 papers
Grants
National Institute of Dental and Craniofacial Research · ZIA
Contact PI · $8.9M · National Institute of Dental & Craniofacial Research
Clinical trials
- 2026–2029
Principal investigator · Recruiting · Phase 1, Phase 2
National Institute of Dental and Craniofacial Research (NIDCR)
- 2022–2024
Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
Principal investigator · Completed · Phase 2
National Institute of Dental and Craniofacial Research (NIDCR)
- 2022–2026
Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia
Principal investigator · Completed · Phase 2
National Institute of Dental and Craniofacial Research (NIDCR)
- 2019–2030
Denosumab Treatment for Fibrous Dysplasia
Principal investigator · Active not recruiting · Phase 2
National Institute of Dental and Craniofacial Research (NIDCR)